Literature DB >> 3154916

Comparison of functional responses of canine coronary artery and saphenous vein.

T Isshiki1, N Akatsuka, T Saito, H Tsuneyoshi, M Ohno, M Nakamura, T Namiki, H Oka.   

Abstract

Functional responses of canine circumflex coronary arteries and saphenous veins before and after grafting surgery were assessed following physiologic and pharmacologic interventions. Developed tension of ringed segments of vessels was recorded isometrically. Dose-dependent responses to norepinephrine revealed significantly greater responses of saphenous veins than coronary arteries (maximal responses were 2.79 +/- 0.45 and 0.44 +/- 0.34 g, respectively; p less than 0.001). Sensitivity to norepinephrine [as evaluated by 50% effective dose (ED50) value] was 3.3 times greater in the saphenous veins (p less than 0.001). STA2, a synthetic thromboxane A2 analog (see Methods), produced similar contractions of both vessels [maximal responses were 2.13 +/- 0.37 g in saphenous vein and 1.64 +/- 0.85 g in coronary artery; p less than not significant (NS)], while sensitivity to STA2 of saphenous veins was 3.1 times greater than that of coronary arteries (p less than 0.001). In contrast to the foregoing responses, coronary arteries demonstrated significantly greater responses to potassium than saphenous veins (maximal responses were 2.16 +/- 0.71 g and 1.40 +/- 0.56 g, respectively; p less than 0.001). Moreover, coronary arteries revealed 1.6 times greater sensitivity than saphenous veins (p less than 0.001). When saphenous veins were transplanted into the femoral artery, the segments of the grafts (2 weeks or 3 months after surgery) revealed 4.0 and 1.7 times greater sensitivity (denervation supersensitivity) to norepinephrine and potassium than those of the control veins (p less than 0.01, respectively). Contractile tension response, however, decreased by at least 50% 3 months after surgery, most probably due to a thickened vessel wall and a reduced compliance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3154916     DOI: 10.1007/bf00054639

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  24 in total

1.  RESPONSES OF CORONARY SMOOTH MUSCLE TO CATECHOLAMINES.

Authors:  R C ZUBERBUHLER; D F BOHR
Journal:  Circ Res       Date:  1965-05       Impact factor: 17.367

2.  Supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U TRENDELENBURG
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

3.  Altered resting membrane potential in the supersensitive vas deferens of the guinea pig.

Authors:  W W Fleming; D P Westfall
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

Review 4.  Postjunctional supersensitivity and subsensitivity of excitable tissues to drugs.

Authors:  W W Fleming; J J McPhillips; D P Westfall
Journal:  Ergeb Physiol       Date:  1973

5.  Changes in vein grafts following aorto-coronary bypass induced by pressure and ischemia.

Authors:  W R Brody; J C Kosek; W W Angell
Journal:  J Thorac Cardiovasc Surg       Date:  1972-12       Impact factor: 5.209

6.  Glyoxylic acid condensation: a new fluorescence method for the histochemical demonstration of biogenic monoamines.

Authors:  S Axelsson; A Björklund; B Falck; O Lindvall; L A Svensson
Journal:  Acta Physiol Scand       Date:  1973-01

7.  Ergonovine-induced spasm of a coronary artery bypass graft.

Authors:  J L Martin; V Kusiak; W J Untereker
Journal:  Int J Cardiol       Date:  1983-05       Impact factor: 4.164

8.  Angiographic documentation of spontaneous spasm of saphenous vein coronary artery bypass graft.

Authors:  P Walinsky
Journal:  Am Heart J       Date:  1982-02       Impact factor: 4.749

9.  Isolated human coronary arteries in response to vasoconstrictor substances.

Authors:  N Toda
Journal:  Am J Physiol       Date:  1983-12

10.  Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium.

Authors:  J G De Mey; P M Vanhoutte
Journal:  Circ Res       Date:  1982-10       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.